Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Cadila-Pharmaceuticals"

26 News Found

Cadila and CII launches joint national campaign for rabies-free India by 2030
Public Health | September 24, 2022

Cadila and CII launches joint national campaign for rabies-free India by 2030

Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone


Cadila launches generic sitagliptin versions to treat uncontrolled type 2 diabetes
News | August 02, 2022

Cadila launches generic sitagliptin versions to treat uncontrolled type 2 diabetes

The two generic drugs have been launched under the brand names Jankey & Sitenali.


Cadila Pharma bags ‘Rising Digital Star’ award at DigipharmaX
News | July 26, 2022

Cadila Pharma bags ‘Rising Digital Star’ award at DigipharmaX

The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.


Pharma industry warming up towards adoption of digital technologies
Digitisation | June 27, 2022

Pharma industry warming up towards adoption of digital technologies

By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities


Indian Pharma Post organizes e-Conference on ‘Role of Digitalization in Pharma Sector’  June 24
Digitisation | June 23, 2022

Indian Pharma Post organizes e-Conference on ‘Role of Digitalization in Pharma Sector’ June 24

Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers


Cadila Pharma launches formulation development lab
News | June 21, 2022

Cadila Pharma launches formulation development lab

The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab


Cadila Pharma launches Belmore to treat uncontrolled LDL-cholesterol
Drug Approval | May 24, 2022

Cadila Pharma launches Belmore to treat uncontrolled LDL-cholesterol

Belmore, the brand name of Bempedoic acid, is a novel drug for the treatment of high LDL-cholesterol.


Cadila Pharma launches world’s first three-dose rabies vaccine
News | April 08, 2022

Cadila Pharma launches world’s first three-dose rabies vaccine

The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.


Gujarat Biotech policy offers incentives to attract small and large firms
News | March 10, 2022

Gujarat Biotech policy offers incentives to attract small and large firms

The Gujarat Biotechnology policy released last month has made radical changes to position the state as a biotechnology hub. It already has a thriving ecosystem of pharma companies and varied suppliers


Cadila Pharma launches lotion to treat dry skin conditions
News | February 11, 2022

Cadila Pharma launches lotion to treat dry skin conditions

Laglo Soft lotion comes with a unique technology that enhances moisturisation and restructures the skin